Send mail to Author

A phase I study of a dual PI3-kinase/mTOR inhibitor BEZ235 in adult patients with relapsed or refractory acute leukemia (Article)

Please indicate your contact information and select, which author you want to contact.



 
 _    _    __   __    _____      ___      _____     _____   
| || | ||  \ \\/ //  / ____||   / _ \\   / ____||  |  ___|| 
| || | ||   \ ` //  / //---`'  | / \ || / //---`'  | ||__   
| \\_/ ||    | ||   \ \\___    | \_/ || \ \\___    | ||__   
 \____//     |_||    \_____||   \___//   \_____||  |_____|| 
  `---`      `-`'     `----`    `---`     `----`   `-----`
 


Back to frontdoor view

OPUS4 Logo